Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Preliminary Data from Study Demonstrates 94% Accuracy in Detecting Aggressive Prostate Cancer 2018-08-13 20:30
China Biologic Names Bing Li as New CEO 2018-08-13 20:00
JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Trastuzumab Biosimilar to Treat Breast Cancer 2018-08-10 10:05
JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Bevacizumab Biosimilar to Treat Lung Cancer 2018-08-10 09:24
US FDA concludes review of Sugar from the first GM sugarcane variety from Centro de Tecnologia Canavieira 2018-08-10 09:00
NCCN Publishes First-Ever U.S. Guidelines for Rare Cancers Associated with Pregnancy 2018-08-09 21:15
I-Mab's Announces China Clinical Trial Approval of Long-acting hGLP-1 to Treat Type 2 Diabetes 2018-08-09 16:16
TOT BIOPHARM raises US$102 million in Series B Financing Round 2018-08-08 19:00
Eurocine Vaccines' Nasal Influenza Vaccine Candidate Immunose(TM) FLU Showed Good Safety in Older Adults 2018-08-08 15:43
VolitionRx Limited Schedules Second Quarter 2018 Earnings Conference Call and Business Update 2018-08-07 20:35
Frost & Sullivan Publishes Quarterly Update on Oramed Pharmaceuticals Inc. - Sufficient funds for clinical development activity over the next 24 months; several clinical milestones are scheduled for 2018 and 2019; as Oramed's clinical progress meets our expectations, stock target price remains at NIS 53.2. 2018-08-07 20:00
Adlai Nortye Announces Engagement of Lars E. Birgerson, M.D., Ph.D., as CDO and President/CEO of Adlai Nortye USA 2018-08-07 01:15
JNCCN -- Journal of the National Comprehensive Cancer Network Strengthens Editorial Focus on Original, Impactful Research into Cancer Care Delivery 2018-08-06 21:30
CureGenetics raises $17 million in Series A Financing 2018-08-06 21:00
AOBiome Therapeutics Announces the Expansion of its Board of Directors 2018-08-06 08:00
China Biologic Reports Financial Results for the Second Quarter of 2018 2018-08-04 04:30
IMPACT Therapeutics Raises $30 Million In Series C Financing 2018-08-03 16:48
Boehringer Ingelheim achieves modest growth in the first half of 2018 2018-08-01 16:00
"Tianfu Talent Recruitment" Launched by Chengdu Hi-Tech Zone First Starts in the UK 2018-08-01 15:41
PENTAX Medical acquires majority stake in PlasmaBiotics SAS, a technology innovator focused on the ultra-fast channel drying and active storage of endoscopes 2018-08-01 15:00
1 333 334 335 336 337 450